P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy

dc.authorwosidkubilay, senol/HJP-0974-2023
dc.contributor.authorKubilay, SA
dc.contributor.authorTurhan, H
dc.contributor.authorErbay, AR
dc.contributor.authorBasar, N
dc.contributor.authorYasar, AS
dc.contributor.authorSahin, O
dc.contributor.authorYetkin, E
dc.date.accessioned2024-08-04T20:30:42Z
dc.date.available2024-08-04T20:30:42Z
dc.date.issued2004
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: P-wave dispersion (PWD) has been reported to be associated with inhomogeneous and discontinuous propagation of sinus impulses. In the present study, we aimed to investigate PWD in patients with dilated cardiomyopathy. Method: The study population consisted of 72 patients with dilated cardiomyopathy and 72 healthy control subjects. Left atrial diameter, left ventricular end-diastolic and end-systolic diameters and left ventricular ejection fraction of all patients and control subjects were measured by means of transthoracic echocardiography. Maximum P-wave duration (Pmaximum) and minimum P-wave duration (Pminimum) were measured from the 12-lead surface electrocardiogram. PWD was calculated as the difference between Pmaximum and Pminimum. Results: Pmaximum and PWD of patients with dilated cardiomyopathy were significantly higher than those of control subjects (Pmaximum: 126 +/- 12 ms vs. 116 10 ms, PWD: 47 +/- 6 ms vs. 38 +/- 7 ms, respectively, P < 0.001 for all). However, there was no statistically significant difference between patient group and control group regarding Pminimum (79 7 ms vs. 78 6 ms, respectively, P = 0.27). Left atrial diameter was significantly higher in patients with dilated cardiomyopathy compared to control subjects (4.51 +/- 0.62 cm vs. 3.60 +/- 0.43 cm, respectively, P < 0.001). Left ventricular ejection fraction was found to be significantly lower in patients with dilated cardiomyopathy compared to control subjects (33 +/- 5% vs. 63 +/- 7%, respectively, P < 0.001). Conclusion: PWD was found to be significantly higher in patients with dilated cardiomyopathy than in healthy control subjects. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.en_US
dc.identifier.doi10.1016/j.ejheart.2003.12.020
dc.identifier.endpage569en_US
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.issue5en_US
dc.identifier.pmid15302004en_US
dc.identifier.scopus2-s2.0-4043103440en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage567en_US
dc.identifier.urihttps://doi.org/10.1016/j.ejheart.2003.12.020
dc.identifier.urihttps://hdl.handle.net/11616/94476
dc.identifier.volume6en_US
dc.identifier.wosWOS:000223497100008en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofEuropean Journal of Heart Failureen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectdilated cardiomyopathyen_US
dc.subjectP-wave dispersionen_US
dc.subjectatrial fibrillationen_US
dc.titleP-wave duration and P-wave dispersion in patients with dilated cardiomyopathyen_US
dc.typeArticleen_US

Dosyalar